Showing results (21-30 of 424) with videos related to
Sort By:
Pageof 43
Cancer Letters|January 8, 2025
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor modelUjjwol Khatri, Mohamed A Gouda, Shriya Pandey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is It All About ME1?Vivek Subbiah, Boyi GanTrends in Cancer|June 26, 2018
Mining Public Databases for Precision OncologyJason Roszik, Vivek SubbiahCancer|October 30, 2022
Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapyAakash Desai, Vivek SubbiahClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?Aakash Desai, Vivek SubbiahCancer Cell|August 30, 2024
Precision oncology across the ages: Impact on children, adolescents, and young adultsVivek Subbiah, Razelle KurzrockEuropean Journal of Cancer (Oxford, England : 1990)|May 9, 2026
The case for tumour-agnostic reimbursement of dual immunotherapyVivek Subbiah, Razelle KurzrockCurrent Opinion in Oncology|April 27, 2011
Phase 1 clinical trials for sarcomas: the cutting edgeVivek Subbiah, Razelle KurzrockJournal of Medical Case Reports|April 11, 2008
Elevated maternal lipoprotein (a) and neonatal renal vein thrombosis: a case reportVivek Subbiah, Prabhu ParimiPageof 43